Bioactive components of Myracrodruon urundeuva against SARS-CoV-2 : a computational study

Detalhes bibliográficos
Autor(a) principal: Alves, Sabrina Kelly Silva
Data de Publicação: 2023
Outros Autores: Sousa, Cássio Silva, Viana, Edilanne Katrine Amparo, Souza, Hellen Cris Araújo, Souza, Maycon Douglas Araújo, Ribeiro, Arthur Serejo Neves, Vale, Vanessa de Sousa do, Islam, Muhammad Torequl, Araújo, Joabe Lima, Rocha, Jefferson Almeida
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UnB
Texto Completo: http://repositorio2.unb.br/jspui/handle/10482/46575
https://doi.org/10.3390/ddc2040039
https://orcid.org/0000-0002-8424-8948
https://orcid.org/0000-0002-4806-9192
Resumo: SARS-CoV-2 (severe acute respiratory distress syndrome coronavirus 2) is the causative agent for the novel coronavirus disease 2019 (COVID-19). It raises serious biosecurity questions due to its high contagious potential, thereby triggering rapid and efficient responses by the scientific community to take necessary actions against viral infections. Cumulative scientific evidence suggests that natural products remain one of the main sources for pharmaceutical consumption. It is due to their wide chemical diversity that they are able to fight against almost all kinds of diseases and disorders in humans and other animals. Knowing the overall facts, this study was carried out to investigate the chemical interactions between the active constituents of a promising medicinal plant, Myracrodruon urundeuva, and some specific proteins of SARS-CoV-2. For this, we used molecular docking to predict the most appropriate orientation by binding a molecule (a ligand) to its receptor (a protein). The best results were evaluated by screening their pharmacokinetic properties using the online tool pkCSM. Findings suggest that among 44 chemical compounds of M. urundeuva, agathisflavone, which is abundantly present in its leaf, exhibited excellent molecular affinity (−9.3 to −9.7 kcal.mol−1) with three functional proteins, namely, Spike, MPro, and RBD of SARS-CoV-2. In conclusion, M. urundeuva might be a good source of antiviral agents. Further studies are required to elucidate the exact mechanism of action of the bioactive compounds of M. urundeuva acting against SARS-CoV-2.
id UNB_8c4664bc89e4c6b1fb7423c309484ba8
oai_identifier_str oai:repositorio2.unb.br:10482/46575
network_acronym_str UNB
network_name_str Repositório Institucional da UnB
repository_id_str
spelling Alves, Sabrina Kelly SilvaSousa, Cássio SilvaViana, Edilanne Katrine AmparoSouza, Hellen Cris AraújoSouza, Maycon Douglas AraújoRibeiro, Arthur Serejo NevesVale, Vanessa de Sousa doIslam, Muhammad TorequlAraújo, Joabe LimaRocha, Jefferson AlmeidaFederal University of Maranhão, Research Group on Medicinal Chemistry and BiotechnologyFederal University of Maranhão, Research Group on Medicinal Chemistry and BiotechnologyFederal University of Maranhão, Research Group on Medicinal Chemistry and BiotechnologyFederal University of Maranhão, Research Group on Medicinal Chemistry and BiotechnologyFederal University of Maranhão, Research Group on Medicinal Chemistry and BiotechnologyFederal University of Maranhão, Research Group on Medicinal Chemistry and BiotechnologyFederal University of Maranhão, Research Group on Medicinal Chemistry and BiotechnologyBangabandhu Sheikh Mujibur Rahman Science and Technology University, Department of PharmacyUniversity of Brasília, Department of Genetics and MorphologyFederal University of Maranhão, Research Group on Medicinal Chemistry and Biotechnology2023-09-29T15:27:21Z2023-09-29T15:27:21Z2023-09-27ALVES, Sabrina Kelly Silva et al. Bioactive components of Myracrodruon urundeuva against SARS-CoV-2: a computational study. Drugs and Drug Candidates, [S.l.], v. 2, n. 4, p. 781–795, 2023. DOI: https://doi.org/10.3390/ddc2040039. Disponível em: https://www.mdpi.com/2813-2998/2/4/39. Acesso em: 29 set. 2023.http://repositorio2.unb.br/jspui/handle/10482/46575https://doi.org/10.3390/ddc2040039https://orcid.org/0000-0002-8424-8948https://orcid.org/0000-0002-4806-9192engMDPI(CC BY) Copyright: © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/)info:eu-repo/semantics/openAccessBioactive components of Myracrodruon urundeuva against SARS-CoV-2 : a computational studyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleAroeiraAcoplamento molecularSARS-CoV-2Propriedades farmacocinéticasSARS-CoV-2 (severe acute respiratory distress syndrome coronavirus 2) is the causative agent for the novel coronavirus disease 2019 (COVID-19). It raises serious biosecurity questions due to its high contagious potential, thereby triggering rapid and efficient responses by the scientific community to take necessary actions against viral infections. Cumulative scientific evidence suggests that natural products remain one of the main sources for pharmaceutical consumption. It is due to their wide chemical diversity that they are able to fight against almost all kinds of diseases and disorders in humans and other animals. Knowing the overall facts, this study was carried out to investigate the chemical interactions between the active constituents of a promising medicinal plant, Myracrodruon urundeuva, and some specific proteins of SARS-CoV-2. For this, we used molecular docking to predict the most appropriate orientation by binding a molecule (a ligand) to its receptor (a protein). The best results were evaluated by screening their pharmacokinetic properties using the online tool pkCSM. Findings suggest that among 44 chemical compounds of M. urundeuva, agathisflavone, which is abundantly present in its leaf, exhibited excellent molecular affinity (−9.3 to −9.7 kcal.mol−1) with three functional proteins, namely, Spike, MPro, and RBD of SARS-CoV-2. In conclusion, M. urundeuva might be a good source of antiviral agents. Further studies are required to elucidate the exact mechanism of action of the bioactive compounds of M. urundeuva acting against SARS-CoV-2.Instituto de Ciências Biológicas (IB)Departamento de Genética e Morfologia (IB GEM)Programa de Pós-Graduação em Nanociência e Nanobiotecnologiareponame:Repositório Institucional da UnBinstname:Universidade de Brasília (UnB)instacron:UNBORIGINALARTIGO_BioactiveComponentsMyracrodruon.pdfARTIGO_BioactiveComponentsMyracrodruon.pdfapplication/pdf3057697http://repositorio2.unb.br/jspui/bitstream/10482/46575/1/ARTIGO_BioactiveComponentsMyracrodruon.pdf826a9e333e71eb1047948a38eb6df481MD51open accessLICENSElicense.txtlicense.txttext/plain102http://repositorio2.unb.br/jspui/bitstream/10482/46575/2/license.txtaed4704d04bb260d4decd80db311aaa5MD52open access10482/465752023-11-21 14:47:32.998open accessoai:repositorio2.unb.br:10482/46575U3VibWlzc8OjbyBlZmV0aXZhZGEgZGUgYWNvcmRvIGNvbSBsaWNlbsOnYSBjb25jZWRpZGEgcGVsbyBhdXRvciBlL291IGRldGVudG9yIGRvcyBkaXJlaXRvcyBhdXRvcmFpcy4KBiblioteca Digital de Teses e DissertaçõesPUBhttps://repositorio.unb.br/oai/requestopendoar:2023-11-21T17:47:32Repositório Institucional da UnB - Universidade de Brasília (UnB)false
dc.title.pt_BR.fl_str_mv Bioactive components of Myracrodruon urundeuva against SARS-CoV-2 : a computational study
title Bioactive components of Myracrodruon urundeuva against SARS-CoV-2 : a computational study
spellingShingle Bioactive components of Myracrodruon urundeuva against SARS-CoV-2 : a computational study
Alves, Sabrina Kelly Silva
Aroeira
Acoplamento molecular
SARS-CoV-2
Propriedades farmacocinéticas
title_short Bioactive components of Myracrodruon urundeuva against SARS-CoV-2 : a computational study
title_full Bioactive components of Myracrodruon urundeuva against SARS-CoV-2 : a computational study
title_fullStr Bioactive components of Myracrodruon urundeuva against SARS-CoV-2 : a computational study
title_full_unstemmed Bioactive components of Myracrodruon urundeuva against SARS-CoV-2 : a computational study
title_sort Bioactive components of Myracrodruon urundeuva against SARS-CoV-2 : a computational study
author Alves, Sabrina Kelly Silva
author_facet Alves, Sabrina Kelly Silva
Sousa, Cássio Silva
Viana, Edilanne Katrine Amparo
Souza, Hellen Cris Araújo
Souza, Maycon Douglas Araújo
Ribeiro, Arthur Serejo Neves
Vale, Vanessa de Sousa do
Islam, Muhammad Torequl
Araújo, Joabe Lima
Rocha, Jefferson Almeida
author_role author
author2 Sousa, Cássio Silva
Viana, Edilanne Katrine Amparo
Souza, Hellen Cris Araújo
Souza, Maycon Douglas Araújo
Ribeiro, Arthur Serejo Neves
Vale, Vanessa de Sousa do
Islam, Muhammad Torequl
Araújo, Joabe Lima
Rocha, Jefferson Almeida
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.affiliation.pt_BR.fl_str_mv Federal University of Maranhão, Research Group on Medicinal Chemistry and Biotechnology
Federal University of Maranhão, Research Group on Medicinal Chemistry and Biotechnology
Federal University of Maranhão, Research Group on Medicinal Chemistry and Biotechnology
Federal University of Maranhão, Research Group on Medicinal Chemistry and Biotechnology
Federal University of Maranhão, Research Group on Medicinal Chemistry and Biotechnology
Federal University of Maranhão, Research Group on Medicinal Chemistry and Biotechnology
Federal University of Maranhão, Research Group on Medicinal Chemistry and Biotechnology
Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Department of Pharmacy
University of Brasília, Department of Genetics and Morphology
Federal University of Maranhão, Research Group on Medicinal Chemistry and Biotechnology
dc.contributor.author.fl_str_mv Alves, Sabrina Kelly Silva
Sousa, Cássio Silva
Viana, Edilanne Katrine Amparo
Souza, Hellen Cris Araújo
Souza, Maycon Douglas Araújo
Ribeiro, Arthur Serejo Neves
Vale, Vanessa de Sousa do
Islam, Muhammad Torequl
Araújo, Joabe Lima
Rocha, Jefferson Almeida
dc.subject.keyword.pt_BR.fl_str_mv Aroeira
Acoplamento molecular
SARS-CoV-2
Propriedades farmacocinéticas
topic Aroeira
Acoplamento molecular
SARS-CoV-2
Propriedades farmacocinéticas
description SARS-CoV-2 (severe acute respiratory distress syndrome coronavirus 2) is the causative agent for the novel coronavirus disease 2019 (COVID-19). It raises serious biosecurity questions due to its high contagious potential, thereby triggering rapid and efficient responses by the scientific community to take necessary actions against viral infections. Cumulative scientific evidence suggests that natural products remain one of the main sources for pharmaceutical consumption. It is due to their wide chemical diversity that they are able to fight against almost all kinds of diseases and disorders in humans and other animals. Knowing the overall facts, this study was carried out to investigate the chemical interactions between the active constituents of a promising medicinal plant, Myracrodruon urundeuva, and some specific proteins of SARS-CoV-2. For this, we used molecular docking to predict the most appropriate orientation by binding a molecule (a ligand) to its receptor (a protein). The best results were evaluated by screening their pharmacokinetic properties using the online tool pkCSM. Findings suggest that among 44 chemical compounds of M. urundeuva, agathisflavone, which is abundantly present in its leaf, exhibited excellent molecular affinity (−9.3 to −9.7 kcal.mol−1) with three functional proteins, namely, Spike, MPro, and RBD of SARS-CoV-2. In conclusion, M. urundeuva might be a good source of antiviral agents. Further studies are required to elucidate the exact mechanism of action of the bioactive compounds of M. urundeuva acting against SARS-CoV-2.
publishDate 2023
dc.date.accessioned.fl_str_mv 2023-09-29T15:27:21Z
dc.date.available.fl_str_mv 2023-09-29T15:27:21Z
dc.date.issued.fl_str_mv 2023-09-27
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv ALVES, Sabrina Kelly Silva et al. Bioactive components of Myracrodruon urundeuva against SARS-CoV-2: a computational study. Drugs and Drug Candidates, [S.l.], v. 2, n. 4, p. 781–795, 2023. DOI: https://doi.org/10.3390/ddc2040039. Disponível em: https://www.mdpi.com/2813-2998/2/4/39. Acesso em: 29 set. 2023.
dc.identifier.uri.fl_str_mv http://repositorio2.unb.br/jspui/handle/10482/46575
dc.identifier.doi.pt_BR.fl_str_mv https://doi.org/10.3390/ddc2040039
dc.identifier.orcid.pt_BR.fl_str_mv https://orcid.org/0000-0002-8424-8948
https://orcid.org/0000-0002-4806-9192
identifier_str_mv ALVES, Sabrina Kelly Silva et al. Bioactive components of Myracrodruon urundeuva against SARS-CoV-2: a computational study. Drugs and Drug Candidates, [S.l.], v. 2, n. 4, p. 781–795, 2023. DOI: https://doi.org/10.3390/ddc2040039. Disponível em: https://www.mdpi.com/2813-2998/2/4/39. Acesso em: 29 set. 2023.
url http://repositorio2.unb.br/jspui/handle/10482/46575
https://doi.org/10.3390/ddc2040039
https://orcid.org/0000-0002-8424-8948
https://orcid.org/0000-0002-4806-9192
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Institucional da UnB
instname:Universidade de Brasília (UnB)
instacron:UNB
instname_str Universidade de Brasília (UnB)
instacron_str UNB
institution UNB
reponame_str Repositório Institucional da UnB
collection Repositório Institucional da UnB
bitstream.url.fl_str_mv http://repositorio2.unb.br/jspui/bitstream/10482/46575/1/ARTIGO_BioactiveComponentsMyracrodruon.pdf
http://repositorio2.unb.br/jspui/bitstream/10482/46575/2/license.txt
bitstream.checksum.fl_str_mv 826a9e333e71eb1047948a38eb6df481
aed4704d04bb260d4decd80db311aaa5
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UnB - Universidade de Brasília (UnB)
repository.mail.fl_str_mv
_version_ 1801863855870050304